home / stock / kzia / kzia quote
Last: | $0.4001 |
---|---|
Change Percent: | 1.04% |
Open: | $0.396 |
Close: | $0.396 |
High: | $0.403 |
Low: | $0.3902 |
Volume: | 58,120 |
Last Trade Date Time: | 10/10/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4001 | $0.396 | $0.396 | $0.403 | $0.3902 | 58,120 | 10-10-2024 |
$0.396 | $0.41 | $0.396 | $0.4115 | $0.3915 | 325,103 | 10-09-2024 |
$0.426 | $0.4099 | $0.426 | $0.428 | $0.4042 | 164,417 | 10-08-2024 |
$0.4154 | $0.435 | $0.4154 | $0.435 | $0.407 | 358,038 | 10-07-2024 |
$0.4402 | $0.4286 | $0.4402 | $0.4557 | $0.4286 | 365,153 | 10-04-2024 |
$0.4286 | $0.425 | $0.4286 | $0.4363 | $0.381 | 447,531 | 10-03-2024 |
$0.4364 | $0.4499 | $0.4364 | $0.5091 | $0.425 | 1,779,022 | 10-02-2024 |
$0.431 | $0.4255 | $0.431 | $0.4399 | $0.401 | 634,385 | 10-01-2024 |
$0.4299 | $0.3996 | $0.4299 | $0.45 | $0.385 | 1,204,159 | 09-30-2024 |
$0.3942 | $0.37 | $0.3942 | $0.3975 | $0.3647 | 823,254 | 09-27-2024 |
$0.3644 | $0.3496 | $0.3644 | $0.3699 | $0.344 | 834,910 | 09-26-2024 |
$0.327 | $0.328 | $0.327 | $0.339 | $0.3117 | 523,667 | 09-25-2024 |
$0.3263 | $0.3344 | $0.3263 | $0.3344 | $0.318 | 242,762 | 09-24-2024 |
$0.3344 | $0.3178 | $0.3344 | $0.3344 | $0.311 | 328,067 | 09-23-2024 |
$0.3247 | $0.33 | $0.3247 | $0.33 | $0.315 | 209,524 | 09-20-2024 |
$0.3303 | $0.333 | $0.3303 | $0.34 | $0.3202 | 457,600 | 09-19-2024 |
$0.34 | $0.3258 | $0.34 | $0.346 | $0.312 | 547,298 | 09-18-2024 |
$0.3202 | $0.3383 | $0.3202 | $0.3397 | $0.315 | 929,560 | 09-17-2024 |
$0.34 | $0.345 | $0.34 | $0.35 | $0.334 | 576,841 | 09-16-2024 |
$0.3431 | $0.3277 | $0.3431 | $0.355 | $0.3231 | 1,444,621 | 09-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
Kazia Therapeutics Limited Website:
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society for Radiation Oncology 66th Annual Meeting ...
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium PR Newswire SYDNEY , Sept. 23, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pl...
2024-09-19 11:00:00 ET September 19, 2024 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherap...